Holen Sie sich die Stockscreener-App
3.22
9.15%
0.27
Handel nachbörslich:
3.28
0.06
+1.86%
Medicus Pharma Ltd Aktie (MDCX) Neueste Nachrichten
Medicus Pharma targets horse cancer with new trial – ICYMI - Proactive financial news
Medicus Pharma to present at BIO 2025 - Proactive financial news
Medicus Pharma to Present at Bio Convention and Expand Cancer Treatment Portfolio - TipRanks
Medicus Pharma Ltd. to Present at 2025 Bio International Convention - Newsfile
BMO Launches Human Capital Factor US Equity ETF - The Globe and Mail
If I Could Only Buy and Hold a Single Stock, This Would Be It. - The Globe and Mail
ISRG Margin Outlook Dips on Tariffs, Demand Signals Stay Strong - The Globe and Mail
Medicus Pharma Ltd. (NASDAQ: MDCX) Strategically Positions Itself in the Rapidly Growing Biotech Market - citybuzz -
Medicus Pharma submits development plan for novel Equine Cancer treatment - Proactive financial news
Medicus Pharma’s (MDCX) “Buy” Rating Reaffirmed at D. Boral Capital - Defense World
Medicus Pharma Ltd. (NASDAQ: MDCX) Positioned for Growth in a $5 Trillion Biotech Market - openPR.com
Should You Invest $1,000 in Verizon Today? - The Globe and Mail
Medicus Pharma prices $7 million share offering - MSN
Medicus Pharma advances cancer patch for horses By Investing.com - Investing.com South Africa
Medicus Pharma submits FDA plan to develop microneedle-based treatment for skin cancer in horses - Proactive financial news
Is Newmont Stock Outperforming the Nasdaq? - The Globe and Mail
Medicus Pharma Submits FDA Plan for Novel Equine Cancer Treatment - TipRanks
Medicus Pharma advances cancer patch for horses - Investing.com
Medicus Pharma Ltd. Announces Submission of Product Development Plan to the Food and Drug Administration (FDA) to Treat External Squamous Cell Carcinoma (SCC) in Horses - Yahoo Finance
5 Monster Stocks to Hold for the Next 10 Years - The Globe and Mail
Certain Common Stock of Medicus Pharma Ltd. are subject to a Lock-Up Agreement Ending on 9-JUN-2025. - MarketScreener
Eli Lilly Stock (LLY) Gets Multiple Wall Street Downgrades - The Globe and Mail
How major US stock indexes fared Thursday, 6/5/2025 - The Globe and Mail
Why Shares of Robinhood Are Surging This Week - The Globe and Mail
The Golden Retracement Keeps Sending Wheat Lower & New Video! - The Globe and Mail
Why Wolfspeed Stock Is Soaring Today - The Globe and Mail
Multiple insider buying at BuildDirect.com (BILD) - The Globe and Mail
Are Options Traders Betting on a Big Move in Autodesk Stock? - The Globe and Mail
Medicus Pharma completes $7 million public offering By Investing.com - Investing.com South Africa
Why Broadcom Stock Blew Past the Market on Monday - The Globe and Mail
Medicus Pharma completes $7 million public offering - Investing.com
Medicus Pharma Secures $7 Million for Cancer Treatment Trials - TipRanks
Medicus Pharma Ltd. Announces Closing of $7.0 Million Public Offering - Newsfile
Medicus Pharma closes $7M public offering - Proactive financial news
2 Nasdaq Stocks to Buy in June - The Globe and Mail
Biotech Stocks Plummet As Public Offerings Shake Market - Finimize
Health Sector Experiences Mixed Fortunes As Trials And Stock Moves Shake Up Market - Finimize
Small cap wrap: ReconAfrica, Charbone Hydrogen, Medicus Pharma.... - Proactive financial news
Sector Update: Health Care - marketscreener.com
Form 424B4 Medicus Pharma Ltd. - StreetInsider
Medicus Pharma Prices $7 Million Public Offering; Shares Fall - marketscreener.com
Medicus Pharma unveils pricing of $7M public offering - Proactive financial news
Medicus Pharma (NASDAQ:MDCX) Upgraded at Wall Street Zen - Defense World
Medicus Pharma’s (MDCX) Buy Rating Reaffirmed at D. Boral Capital - Defense World
Medicus Pharma Ltd. Launches $7 Million Public Offering to Advance Cancer Treatment Trials - TipRanks
Medicus Pharma Secures $7M Funding to Advance Revolutionary Skin Cancer Patch Through Phase 2 Trials - Stock Titan
Medicus Pharma Ltd. Announces Pricing of $7.0 Million Public Offering - Newsfile
Definity Financial Corporation Announces Increased Size of Previously Announced Private Placements of Common Shares to $385 million - The Globe and Mail
Medicus Pharma Files For Resale From Time To Time Of Up To 3.7 Mln Common Shares - marketscreener.com
0.53%
0.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):